Detecting and characterizing melanoma cells in the bloodstream

Immuno-electrochemical Detection and Characterization of Melanoma Circulating Cells

NIH-funded research Wm S. Middleton Memorial Veterans Hosp · NIH-10975910

This study is looking at ways to find tiny cancer cells in the blood of people with melanoma, which can help doctors understand how the disease is spreading and improve monitoring, so patients can get the right care sooner.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWm S. Middleton Memorial Veterans Hosp NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-10975910 on NIH RePORTER

What this research studies

This research focuses on improving the detection of circulating tumor cells (CTCs) in patients with melanoma, which can indicate the presence of metastatic disease. By analyzing blood samples, the study aims to identify reliable biomarkers that can help assess and monitor the risk of melanoma progression. The approach involves advanced immuno-electrochemical techniques to enhance the sensitivity of CTC detection, potentially leading to earlier interventions for patients. The goal is to provide a better understanding of how melanoma spreads and to improve patient outcomes through more effective monitoring.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with melanoma, particularly those in early stages or at risk of developing metastatic disease.

Not a fit: Patients with non-melanoma skin cancers or those who are not currently diagnosed with melanoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection of melanoma metastasis, allowing for timely and potentially life-saving treatments.

How similar studies have performed: Previous research has shown promise in using circulating tumor cells as biomarkers for cancer monitoring, indicating that this approach has potential for success.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.